Page last updated: 2024-08-18

cyclohexanol and Liver Dysfunction

cyclohexanol has been researched along with Liver Dysfunction in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (20.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baird-Bellaire, S; Behrle, JA; Nichols, AI; Parker, VD; Patat, A; Paul, J	1
Alves, G; Falcão, A; Llerena, A; Magalhães, P	1
Dorne, JL; Renwick, AG; Slob, W; Walton, K	1
Dubarek, W; Kucia, K	1
Nagashima, H; Taketa, K; Watanabe, M; Yamamoto, Y	1

Reviews

2 review(s) available for cyclohexanol and Liver Dysfunction

Article	Year
Venlafaxine pharmacokinetics focused on drug metabolism and potential biomarkers. Drug metabolism and drug interactions, 2014, Volume: 29, Issue:3 Topics: Age Factors; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Biomarkers; Body Weight; Cyclohexanols; Cytochrome P-450 Enzyme System; Genetic Markers; Humans; Kidney Diseases; Liver Diseases; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Sex Factors; Smoking; Venlafaxine Hydrochloride	2014
[Applications and safety of modern antidepressants in patients with liver diseases]. Wiadomosci lekarskie (Warsaw, Poland : 1960), 2007, Volume: 60, Issue:1-2 Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Cyclopropanes; Depressive Disorder; Humans; Liver Diseases; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Piperazines; Risk Factors; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride	2007

Article

Year

Venlafaxine pharmacokinetics focused on drug metabolism and potential biomarkers.

Drug metabolism and drug interactions, 2014, Volume: 29, Issue:3

Topics: Age Factors; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Biomarkers; Body Weight; Cyclohexanols; Cytochrome P-450 Enzyme System; Genetic Markers; Humans; Kidney Diseases; Liver Diseases; Polymorphism, Genetic; Selective Serotonin Reuptake Inhibitors; Sex Factors; Smoking; Venlafaxine Hydrochloride

2014

[Applications and safety of modern antidepressants in patients with liver diseases].

Wiadomosci lekarskie (Warsaw, Poland : 1960), 2007, Volume: 60, Issue:1-2

Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Cyclopropanes; Depressive Disorder; Humans; Liver Diseases; Mianserin; Milnacipran; Mirtazapine; Monoamine Oxidase Inhibitors; Piperazines; Risk Factors; Selective Serotonin Reuptake Inhibitors; Triazoles; Venlafaxine Hydrochloride

2007

Trials

1 trial(s) available for cyclohexanol and Liver Dysfunction

Article	Year
An open-label, single-dose, parallel-group study of the effects of chronic hepatic impairment on the safety and pharmacokinetics of desvenlafaxine. Clinical therapeutics, 2013, Volume: 35, Issue:6 Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclohexanols; Desvenlafaxine Succinate; Female; Humans; Liver; Liver Diseases; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Young Adult	2013

Article

Year

An open-label, single-dose, parallel-group study of the effects of chronic hepatic impairment on the safety and pharmacokinetics of desvenlafaxine.

Clinical therapeutics, 2013, Volume: 35, Issue:6

Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclohexanols; Desvenlafaxine Succinate; Female; Humans; Liver; Liver Diseases; Male; Middle Aged; Neurotransmitter Uptake Inhibitors; Young Adult

2013

Other Studies

2 other study(ies) available for cyclohexanol and Liver Dysfunction

Article	Year
Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate? Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2002, Volume: 40, Issue:11 Topics: Adult; Aged; Aging; Benzhydryl Compounds; Cresols; Cyclohexanols; Cytochrome P-450 CYP2D6; Debrisoquin; Desipramine; Encainide; Ethnicity; Genetic Variation; Humans; Hydroxylation; Infant; Infant, Newborn; Kidney Diseases; Kinetics; Liver Diseases; Metabolic Clearance Rate; Metoprolol; Phenylpropanolamine; Polymorphism, Genetic; Propafenone; Substrate Specificity; Tolterodine Tartrate; Venlafaxine Hydrochloride	2002
Effect of nicomol on HDL cholesterol level. Acta medica Okayama, 1979, Volume: 33, Issue:4 Topics: Adult; Arteriosclerosis; Cholesterol; Cyclohexanols; Female; Humans; Lipoproteins, HDL; Liver Diseases; Male; Middle Aged; Nicotinic Acids	1979

Article

Year

Human variability in polymorphic CYP2D6 metabolism: is the kinetic default uncertainty factor adequate?

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2002, Volume: 40, Issue:11

Topics: Adult; Aged; Aging; Benzhydryl Compounds; Cresols; Cyclohexanols; Cytochrome P-450 CYP2D6; Debrisoquin; Desipramine; Encainide; Ethnicity; Genetic Variation; Humans; Hydroxylation; Infant; Infant, Newborn; Kidney Diseases; Kinetics; Liver Diseases; Metabolic Clearance Rate; Metoprolol; Phenylpropanolamine; Polymorphism, Genetic; Propafenone; Substrate Specificity; Tolterodine Tartrate; Venlafaxine Hydrochloride

2002

Effect of nicomol on HDL cholesterol level.

Acta medica Okayama, 1979, Volume: 33, Issue:4

Topics: Adult; Arteriosclerosis; Cholesterol; Cyclohexanols; Female; Humans; Lipoproteins, HDL; Liver Diseases; Male; Middle Aged; Nicotinic Acids

1979